.png){kind=icon}
.png){kind=icon}
Return
Quality of Life in Patients with Retinal Vein Occlusion: A Review of the Literature
.png){kind=icon}
PRE
AI
K
G
T
I
DOI：10.1159/000551378.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Background: Retinal vein occlusion (RVO) is the second most common retinal vascular disorder after diabetic retinopathy and represents a significant cause of visual loss worldwide. Beyond visual impairment, RVO can profoundly affect patients' wellbeing and overall vision-related quality of life (QoL). Increasing evidence indicates that vision-related disability contributes to increased levels of anxiety and social limitations in affected individuals. This narrative review synthesizes current evidence on QoL outcomes in patients with RVO, highlights factors influencing psychological outcomes, and explores the role of treatment interventions in modifying patient-reported wellbeing. Summary: Across the included studies, patients with RVO reported significantly reduced vision-related QoL compared with healthy controls, as assessed by the NEI VFQ-25. Anti-vascular endothelial growth factor (VEGF) therapies, including ranibizumab, aflibercept, and bevacizumab, consistently improved QoL scores, with gains evident as early as 1 month and sustained up to 12 months. Improvements were most pronounced in visual function and daily activity subscales, although near vision, mental health, and social functioning frequently remained below normal levels. Predictors of better QoL outcomes included stereopsis, fellow eye vision, and central macular thickness reduction, while systemic comorbidities such as hypertension and diabetes were associated with poorer outcomes. Key Messages: While anti-VEGF therapy improves QoL in patients with RVO, long-term management should extend beyond vision restoration. A multidisciplinary approach - integrating ophthalmology, primary care, and psychological support - is essential to address systemic risk factors, reduce treatment burden, and improve overall wellbeing. Future studies should explore long-term QoL outcomes and evaluate strategies that support holistic, patient-centered care.
Keywords:
Retinal vein occlusion
Quality of life
Anxiety
Anti-vascular endothelial growth factor injections
Intravitreal injections
Journal
O
IF:
1.9
Papers:
35
Citations:
2.7K
Organization
Cited Papers